Table of Contents

company-logo

Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar in Taiwan and the United States. The company focuses on delivering biosimilars which target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. Its products pipeline includes TX01 and TX-05 which have completed Phase III clinical trials; TX-04 and TX-16 that are in Phase I clinical trial; and TX-52 and other products which are in pre-clinical trial. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.

Tanvex BioPharma Dividend Announcement

• Tanvex BioPharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Tanvex BioPharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Tanvex BioPharma Dividend History

Tanvex BioPharma Dividend Yield

Tanvex BioPharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Tanvex BioPharma stock? Use our calculator to estimate your expected dividend yield:

Tanvex BioPharma Financial Ratios

P/E ratio-5.51
PEG ratio-0.05
P/B ratio6.74
ROE-177.47%
Payout ratio0.00%
Current ratio3.64
Quick ratio3.32
Cash Ratio2.72

Tanvex BioPharma Dividend FAQ

Does Tanvex BioPharma stock pay dividends?
Tanvex BioPharma does not currently pay dividends to its shareholders.
Has Tanvex BioPharma ever paid a dividend?
No, Tanvex BioPharma has no a history of paying dividends to its shareholders. Tanvex BioPharma is not known for its dividend payments.
Why doesn't Tanvex BioPharma pay dividends?
There are several potential reasons why Tanvex BioPharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Tanvex BioPharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Tanvex BioPharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Tanvex BioPharma a dividend aristocrat?
Tanvex BioPharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Tanvex BioPharma a dividend king?
Tanvex BioPharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Tanvex BioPharma a dividend stock?
No, Tanvex BioPharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Tanvex BioPharma stocks?
To buy Tanvex BioPharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Tanvex BioPharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.